Tokyo, Japan / Denver, USA – November 24, 2025 – PlacidWay Medical Tourism, a global leader in connecting international patients with world-class healthcare providers, today proudly announces a strategic partnership with HELENE BioMed Group, one of Japan’s most advanced and scientifically rigorous regenerative medicine groups.
This landmark collaboration is set to dramatically increase global accessibility to Japan’s latest breakthroughs in stem cell and regenerative therapies, offering renewed hope to patients suffering from chronic and life-altering conditions such as Type 2 diabetes, hormonal imbalance, osteoarthritis, neurological degeneration, autoimmune diseases, and metabolic syndromes.
The partnership positions Japan as a rapidly emerging global powerhouse in regenerative medicine, with HELENE BioMed Group playing a pivotal role in advancing precision cellular therapies supported by exceptional clinical outcomes, proprietary technology, and government-regulated excellence.
Japan Emerges as a Global Leader in Regenerative Medicine
Japan has become one of the world’s most progressive environments for regenerative medicine, supported by forward-thinking legislation, strict safety standards, and government-backed innovation strategies. Within this ecosystem, HELENE BioMed Group stands as a benchmark institution, redefining the future of cellular medicine.
With over 11 years of clinical experience and more than 16,000 treated cases, HELENE has established itself as a center of excellence for high-concentration, personalized cell therapies including:
-
High-Dose Autologous Mesenchymal Stem Cell (MSC) Therapy (up to 2 Billion cells per dose). *The actual dosage administered is subject to the physician’s prescription
-
NK Cell Therapy for immune system optimization and cancer prevention.
-
Proprietary R&D, including the "HELENE Medium," exclusively designed for superior MSCs cultivation.
-
Advanced treatments targeting neurological, degenerative joints, metabolic, hormonal, and aging-related conditions
Backed by an in-house ISO 9001-certified Cell Processing Center in Tokyo and more than 20 Japanese government-approved regenerative medicine licenses, HELENE utilizes proprietary technologies like the HELENE Medium to achieve superior cell potency and therapeutic outcomes.
HELENE Clinical Excellence
HELENE World-Class Labs
Gangnam International Medical Center
Transforming Access for Chronic Disease Patients Worldwide
Through this partnership, patients battling conditions previously considered difficult to treat now gain access to some of the world’s most advanced regenerative protocols, including treatment pathways for:
Leadership Perspectives
Dr. Takaaki Matsuoka, MD, PhD, MBA, Group Founder and CEO of HELENE BioMed Group, highlights the strategic impact:
Pramod Goel, CEO and Founder of PlacidWay Medical Tourism, emphasizes the power of global access:
About HELENE BioMed Group
Founded in 2013, HELENE BioMed Group operates as a global leader in Regenerative Medicine with headquarters in Japan, supported by strategic hubs in London and the UAE. With over 300 in-house specialists and 1,200 global affiliates, the group delivers proprietary, high-precision cell therapies through advanced research, clinical excellence, and ethical practices.
Key highlights:
-
In-house ISO-certified Cell Processing Center
-
16,000+ treated cases
-
Global operations across Asia, U.K. & Middle East
-
Advisory board featuring global medical experts and former Japanese government officials
-
Pioneer of personalized cellular treatment systems
About PlacidWay Medical Tourism
PlacidWay is a global medical tourism platform connecting patients with accredited healthcare providers in over 50 countries. Through AI-enabled search, multilingual coordination, and end-to-end medical travel support, PlacidWay empowers patients to confidently navigate complex healthcare decisions and access advanced treatments worldwide.
PlacidWay’s mission is to deliver Your Health. Your Choice. Your Hope.
The Impact of This Alliance
This strategic partnership will:
A New Era of Medical Access
Together, PlacidWay and HELENE BioMed Group are transforming how regenerative medicine reaches patients worldwide — combining Japanese scientific excellence with global AI-powered accessibility to serve humanity’s growing healthcare needs.
.jpg)
.jpg)
Share this listing